By Derrick Bryson Taylor While many European countries have seen an uptick ... sense of the new rules of entry into the European Union. The European Medicines Agency cleared the Pfizer-BioNTech ...
Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in adolescents, bolstering ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Bowers added that to increase access to the latest drugs, the "cancer system" must be organized in such a way as to ...
Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents ...
Pharmaceutical Technology on MSN3d
Gavi to obtain 500,000 mpox vaccine doses from Bavarian NordicGavi (the Global Alliance for Vaccines and Immunization) has entered an advance purchase agreement with Bavarian Nordic to ...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...
4d
Valneva SE (VALN) said that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada to ...
Clinical-stage biotech PharmAust has submitted a request for orphan medicinal product designation (OMPD) to the European ...
Bavarian Nordic, a leading global supplier of travel vaccines, today announced the commercial availability of VAXCHORA®—the ...
ThePrint on MSN4d
Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavirGranting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback